FDA Approved: ILARIS — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved ILARIS (canakinumab) under the original application for treatment of cryopyrin-associated periodic syndromes, including familial cold autoinfla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryopyrin-associated Periodic Syndromes
• Familial Cold Autoinflammatory Syndrome
• Muckle-wells Syndrome

Drugs mentioned

• ILARIS (canakinumab)

Snippet

ORIG AP for ILARIS (CANAKINUMAB)